I've been keeping an eye on EYE, the optical retailer behind over 1,300 stores like America's Best and Eyeglass World. In the latest session, shares fell 22.13%, closing at $16.31 after the prior close of $20.94. This move came right after a Q1 earnings report that mixed profitability strength with a revenue shortfall—investors zeroed in on the miss, even as margins improved.
National Vision posted Q1 net revenue of $543.9 million, a 6.6% year-over-year increase, but it came in just under the $545.13 million consensus estimate. Adjusted comparable store sales grew 4.5%, in line with mid-single-digit expectations, despite headwinds from weather and macro factors hitting cash-pay customers. On the profitability side, things looked solid: adjusted operating income reached $55.5 million, with margins expanding 210 basis points to 10.2%. Adjusted diluted EPS came in at $0.45, beating the $0.43 forecast and improving from $0.34 a year ago. From what I see, the market's reaction overlooked these gains from premium products and cost controls in favor of the top-line disappointment.
The team reaffirmed its FY2026 outlook, with net revenue projected at $2.03-$2.09 billion and adjusted diluted EPS at $0.85-$1.09. They plan 30-35 new stores, primarily America's Best, offset by 10-15 closures for net growth of 20-25 units. Capex is set at $73-$78 million to fund modernization efforts, even as e-commerce competition pressures traffic. One thing that stands out is their confidence in executing amid these challenges.
Volume spiked to over 7.8 million shares—more than five times the 1.4 million average—showing the strong selling pressure after earnings. This contrasted with peers: the consumer discretionary ETF XLY stayed near flat, while staples ETF XLP ticked higher. Shares opened at $18.99 and gapped down, breaking support near $20.66 to reach a 52-week low around $14.75. I also checked this using Tickeron’s AI Screener to compare EYE against retail peers, and the technical breakdown fits the sector's cautious tone.
In my own trading research, I often turn to Tickeron’s Trending AI Robots page, which tracks the platform’s top AI-driven bots in live markets. Scanning thousands of tickers, it highlights leaders in risk-adjusted returns across strategies like trend-following, mean reversion, and momentum. Each shows timeframe, win rate, average return, and symbols traded, so you can filter by metrics or assets. I've found it useful for spotting proven performers to potentially add to my approach—worth checking out if you're evaluating automated edges.
I'm watching Q2 comparable store sales closely for signs of continued mid-single-digit growth, especially with premiumization underway. Broader retail traffic and spending data could shift sentiment soon. Analyst views remain steady for now, though inflation and e-commerce risks persist. The next earnings in August will be key for testing guidance, particularly on store growth and margins in this uneven environment. This is important because it could clarify if the sell-off presents a longer-term opportunity.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where EYE advanced for three days, in of 284 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EYE's RSI Indicator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for EYE just turned positive on June 01, 2026. Looking at past instances where EYE's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
EYE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on May 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on EYE as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EYE declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for EYE entered a downward trend on May 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.559) is normal, around the industry mean (4.582). P/E Ratio (28.333) is within average values for comparable stocks, (28.344). EYE's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.259). EYE has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (0.648) is also within normal values, averaging (1.232).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EYE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EYE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of retail locations offering eye exams, eyeglasses and contact lenses
Industry SpecialtyStores